Optimal measuring timing of cystatin C for early detection of contrast-induced acute kidney injury: A systematic review and meta-analysis

Chu Ting Chen, Ling Yin Chang, Ching Wei Chuang, Shih Ching Wang, Ming Chang Kao, I. Shiang Tzeng, Ko Lin Kuo, Chin Chieh Wu, Pei Shan Tsai, Chun Jen Huang

Research output: Contribution to journalArticle

Abstract

Objective: The optimal measuring timing of serum/plasma Cystatin C (CysC) for early detection of contrast-induced acute kidney injury (CIAKI) remains un-studied. We elucidated further on this issue. Methods: We searched PubMed, MEDLINE, and Embase from inception until March 2018 for studies evaluating diagnostic accuracy of CysC for detecting CIAKI in patients exposed to contrast agents during diagnostic examinations or cardiac/peripheral catheterizations. Results: A total of 10 relevant studies, comprising 2554 patients, were included and divided into the <24 -h and 24 -h groups based on CysC measuring timing (i.e., hours after contrast agent exposure). Compared with creatinine, pooled diagnostic odds ratio of CysC for detecting CIAKI of the <24 -h and 24 -h groups was 7.59 (95 % confidence interval [CI]: 1.31–44.08) and 53.81 (95 % CI: 13.57–213.26). Pooled sensitivity of the <24 -h and 24 -h groups was 0.81 and 0.88. Pooled specificity of the <24 -h and 24 -h groups was 0.64 and 0.88, respectively. Area under the hierarchical summary receiver operating characteristic curve of the <24 -h and 24 -h groups was 0.75 and 0.93. Conclusions: Measuring CysC at 24 h after contrast agent exposure shows higher diagnostic accuracy for early detection of CIAKI than measuring CysC at <24 h after contrast agent exposure.

Original languageEnglish
Pages (from-to)65-73
Number of pages9
JournalToxicology Letters
Volume318
DOIs
Publication statusPublished - Jan 2020

Fingerprint

Cystatin C
Acute Kidney Injury
Meta-Analysis
Contrast Media
Peripheral Catheterization
Confidence Intervals
Cardiac Catheterization
PubMed
MEDLINE
ROC Curve
Creatinine
Odds Ratio
Plasmas
Serum

Keywords

  • AKI
  • Biomarker
  • Contrast agent
  • Creatinine
  • Cystatin C

ASJC Scopus subject areas

  • Toxicology

Cite this

Optimal measuring timing of cystatin C for early detection of contrast-induced acute kidney injury : A systematic review and meta-analysis. / Chen, Chu Ting; Chang, Ling Yin; Chuang, Ching Wei; Wang, Shih Ching; Kao, Ming Chang; Tzeng, I. Shiang; Kuo, Ko Lin; Wu, Chin Chieh; Tsai, Pei Shan; Huang, Chun Jen.

In: Toxicology Letters, Vol. 318, 01.2020, p. 65-73.

Research output: Contribution to journalArticle

Chen, Chu Ting ; Chang, Ling Yin ; Chuang, Ching Wei ; Wang, Shih Ching ; Kao, Ming Chang ; Tzeng, I. Shiang ; Kuo, Ko Lin ; Wu, Chin Chieh ; Tsai, Pei Shan ; Huang, Chun Jen. / Optimal measuring timing of cystatin C for early detection of contrast-induced acute kidney injury : A systematic review and meta-analysis. In: Toxicology Letters. 2020 ; Vol. 318. pp. 65-73.
@article{47df7f7d58c042cc9e22988d00594996,
title = "Optimal measuring timing of cystatin C for early detection of contrast-induced acute kidney injury: A systematic review and meta-analysis",
abstract = "Objective: The optimal measuring timing of serum/plasma Cystatin C (CysC) for early detection of contrast-induced acute kidney injury (CIAKI) remains un-studied. We elucidated further on this issue. Methods: We searched PubMed, MEDLINE, and Embase from inception until March 2018 for studies evaluating diagnostic accuracy of CysC for detecting CIAKI in patients exposed to contrast agents during diagnostic examinations or cardiac/peripheral catheterizations. Results: A total of 10 relevant studies, comprising 2554 patients, were included and divided into the <24 -h and 24 -h groups based on CysC measuring timing (i.e., hours after contrast agent exposure). Compared with creatinine, pooled diagnostic odds ratio of CysC for detecting CIAKI of the <24 -h and 24 -h groups was 7.59 (95 {\%} confidence interval [CI]: 1.31–44.08) and 53.81 (95 {\%} CI: 13.57–213.26). Pooled sensitivity of the <24 -h and 24 -h groups was 0.81 and 0.88. Pooled specificity of the <24 -h and 24 -h groups was 0.64 and 0.88, respectively. Area under the hierarchical summary receiver operating characteristic curve of the <24 -h and 24 -h groups was 0.75 and 0.93. Conclusions: Measuring CysC at 24 h after contrast agent exposure shows higher diagnostic accuracy for early detection of CIAKI than measuring CysC at <24 h after contrast agent exposure.",
keywords = "AKI, Biomarker, Contrast agent, Creatinine, Cystatin C",
author = "Chen, {Chu Ting} and Chang, {Ling Yin} and Chuang, {Ching Wei} and Wang, {Shih Ching} and Kao, {Ming Chang} and Tzeng, {I. Shiang} and Kuo, {Ko Lin} and Wu, {Chin Chieh} and Tsai, {Pei Shan} and Huang, {Chun Jen}",
year = "2020",
month = "1",
doi = "10.1016/j.toxlet.2019.10.011",
language = "English",
volume = "318",
pages = "65--73",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Optimal measuring timing of cystatin C for early detection of contrast-induced acute kidney injury

T2 - A systematic review and meta-analysis

AU - Chen, Chu Ting

AU - Chang, Ling Yin

AU - Chuang, Ching Wei

AU - Wang, Shih Ching

AU - Kao, Ming Chang

AU - Tzeng, I. Shiang

AU - Kuo, Ko Lin

AU - Wu, Chin Chieh

AU - Tsai, Pei Shan

AU - Huang, Chun Jen

PY - 2020/1

Y1 - 2020/1

N2 - Objective: The optimal measuring timing of serum/plasma Cystatin C (CysC) for early detection of contrast-induced acute kidney injury (CIAKI) remains un-studied. We elucidated further on this issue. Methods: We searched PubMed, MEDLINE, and Embase from inception until March 2018 for studies evaluating diagnostic accuracy of CysC for detecting CIAKI in patients exposed to contrast agents during diagnostic examinations or cardiac/peripheral catheterizations. Results: A total of 10 relevant studies, comprising 2554 patients, were included and divided into the <24 -h and 24 -h groups based on CysC measuring timing (i.e., hours after contrast agent exposure). Compared with creatinine, pooled diagnostic odds ratio of CysC for detecting CIAKI of the <24 -h and 24 -h groups was 7.59 (95 % confidence interval [CI]: 1.31–44.08) and 53.81 (95 % CI: 13.57–213.26). Pooled sensitivity of the <24 -h and 24 -h groups was 0.81 and 0.88. Pooled specificity of the <24 -h and 24 -h groups was 0.64 and 0.88, respectively. Area under the hierarchical summary receiver operating characteristic curve of the <24 -h and 24 -h groups was 0.75 and 0.93. Conclusions: Measuring CysC at 24 h after contrast agent exposure shows higher diagnostic accuracy for early detection of CIAKI than measuring CysC at <24 h after contrast agent exposure.

AB - Objective: The optimal measuring timing of serum/plasma Cystatin C (CysC) for early detection of contrast-induced acute kidney injury (CIAKI) remains un-studied. We elucidated further on this issue. Methods: We searched PubMed, MEDLINE, and Embase from inception until March 2018 for studies evaluating diagnostic accuracy of CysC for detecting CIAKI in patients exposed to contrast agents during diagnostic examinations or cardiac/peripheral catheterizations. Results: A total of 10 relevant studies, comprising 2554 patients, were included and divided into the <24 -h and 24 -h groups based on CysC measuring timing (i.e., hours after contrast agent exposure). Compared with creatinine, pooled diagnostic odds ratio of CysC for detecting CIAKI of the <24 -h and 24 -h groups was 7.59 (95 % confidence interval [CI]: 1.31–44.08) and 53.81 (95 % CI: 13.57–213.26). Pooled sensitivity of the <24 -h and 24 -h groups was 0.81 and 0.88. Pooled specificity of the <24 -h and 24 -h groups was 0.64 and 0.88, respectively. Area under the hierarchical summary receiver operating characteristic curve of the <24 -h and 24 -h groups was 0.75 and 0.93. Conclusions: Measuring CysC at 24 h after contrast agent exposure shows higher diagnostic accuracy for early detection of CIAKI than measuring CysC at <24 h after contrast agent exposure.

KW - AKI

KW - Biomarker

KW - Contrast agent

KW - Creatinine

KW - Cystatin C

UR - http://www.scopus.com/inward/record.url?scp=85074364347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074364347&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2019.10.011

DO - 10.1016/j.toxlet.2019.10.011

M3 - Article

C2 - 31654803

AN - SCOPUS:85074364347

VL - 318

SP - 65

EP - 73

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

ER -